Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Dec 16;272(1):69.
doi: 10.1007/s00415-024-12819-x.

Prognostic factors affecting ALS progression through disease tollgates

Affiliations

Prognostic factors affecting ALS progression through disease tollgates

Haoran Wu et al. J Neurol. .

Abstract

Background and objectives: Understanding factors affecting the timing of critical clinical events in ALS progression.

Methods: We captured ALS progression based on the timing of critical events (tollgates), by augmenting 6366 patients' data from the PRO-ACT database with tollgate-passed information using classification. Time trajectories of passing ALS tollgates after the first visit were derived using Kaplan-Meier analyses. The significant prognostic factors were found using log-rank tests. Decision-tree-based classifications identified significant ALS phenotypes characterized by the list of body segments involved at the first visit.

Results: Standard (e.g., gender and onset type) and tollgate-related (phenotype and initial tollgate level) prognostic factors affect the timing of ALS tollgates. For instance, by the third year after the first visit, 80-100% of bulbar-onset patients vs. 43-48% of limb-onset patients, and 65-73% of females vs. 42-49% of males lost the ability to talk and started using a feeding tube. Compared to the standard factors, tollgate-related factors had a stronger effect on ALS progression. The initial impairment level significantly impacted subsequent ALS progression in a segment while affected segment combinations further characterized progression speed. For instance, patients with normal speech (Tollgate Level 0) at the first visit had less than a 10% likelihood of losing speech within a year, while for patients with Tollgate Level 1 (affected speech), this likelihood varied between 23 and 53% based on additional segment (leg) involvement.

Conclusions: Tollgate- and phenotype-related factors have a strong effect on the timing of ALS tollgates. All factors should be jointly considered to better characterize patient groups with different progression aggressiveness.

Keywords: Amyotrophic lateral sclerosis tollgates; Disease progression; Kaplan–Meier analysis; Prognostic factors; Time trajectory projection.

PubMed Disclaimer

Conflict of interest statement

Declarations. Conflicts of interest: The authors report no competing interests. Ethics approval: This study was reviewed by the Mayo Clinic Institutional Review Board and deemed as an exempt study. Consent to participate: Not applicable. Consent for publication: Not applicable.

Similar articles

References

    1. Morris J (2015) Amyotrophic lateral sclerosis (ALS) and related motor neuron diseases: an overview. Neurodiagn J 55(3):180–194 - PubMed
    1. Kiernan MC, Vucic S, Cheah BC et al (2011) Amyotrophic lateral sclerosis. The Lancet 377(9769):942–955
    1. Thakore NJ, Lapin BR, Pioro EP, Pooled Resource Open-Access ALS Clinical Trials Consortium (2020) Stage-specific Riluzole effect in amyotrophic lateral sclerosis: a retrospective study. Amyotroph Lateral Scler Frontotemporal Degener 21(1–2):140–143
    1. Del Aguila MA, Longstreth WT, McGuire V, Koepsell TD, Van Belle G (2003) Prognosis in amyotrophic lateral sclerosis: a population-based study. Neurology 60(5):813–819 - PubMed
    1. Abe K, Aoki M, Tsuji S et al (2017) Safety and efficacy of edaravone in well defined patients with amyotrophic lateral sclerosis: a randomised, double-blind, placebo-controlled trial. Lancet Neurol 16(7):505–512

LinkOut - more resources